The endocannabinoid system as a target for the treatment of motor dysfunction

Por Fernández-Ruiz, Javier
Publicado em 2009

The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes

Por Fernández‐Ruiz, Javier
Publicado no Br J Pharmacol (2018)

Cannabinoid signaling system: Does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?

Por Gómez, María, Hernández, Mariluz, Fernández-Ruiz, Javier
Publicado em 2008

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

Por Fernández‐Ruiz, Javier, Hernández, Mariluz, Ramos, José A.
Publicado no CNS Neurosci Ther (2010)

Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications

Por Fernández-Ruiz, Javier, Moro, María A., Martínez-Orgado, José
Publicado no Neurotherapeutics (2015)

Effects of cannabinoids on adrenaline release from adrenal medullary cells

Por Niederhoffer, Nathalie, Hansen, Henrik H, Fernandez-Ruiz, Javier J, Szabo, Bela
Publicado em 2001

Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia

Por García, Concepción, Palomo‐Garo, Cristina, Gómez‐Gálvez, Yolanda, Fernández‐Ruiz, Javier
Publicado no Br J Pharmacol (2015)

Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors

Por Valdeolivas, Sara, Satta, Valentina, Pertwee, Roger G., Fernández-Ruiz, Javier, Sagredo, Onintza
Publicado em 2012

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

Por Valdeolivas, Sara, Sagredo, Onintza, Delgado, Mercedes, Pozo, Miguel A., Fernández-Ruiz, Javier
Publicado no Int J Mol Sci (2017)

Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1(G93A) Transgenic Mice and Evaluation of a Sativex(®)‐like Combination of Phytocannabinoids: Interest for...

Por Moreno‐Martet, Miguel, Espejo‐Porras, Francisco, Fernández‐Ruiz, Javier, de Lago, Eva
Publicado no CNS Neurosci Ther (2014)

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease

Por Burgaz, Sonia, García, Concepción, Gómez-Cañas, Maria, Muñoz, Eduardo, Fernández-Ruiz, Javier
Publicado no Molecules (2019)

SHORT-TERM EXPOSURE TO ALCOHOL IN RATS AFFECTS BRAIN LEVELS OF ANANDAMIDE, OTHER N-ACYLETHANOLAMINES AND 2-ARACHIDONOYL-GLYCEROL

Por Rubio, Marina, McHugh, Douglas, Fernández-Ruiz, Javier, Bradshaw, Heather, Walker, J. Michael
Publicado em 2007

Targeting Cannabinoid CB(2) Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

Por Navarro, Gemma, Morales, Paula, Rodríguez-Cueto, Carmen, Fernández-Ruiz, Javier, Jagerovic, Nadine, Franco, Rafael
Publicado no Front Neurosci (2016)

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Ta...

Por Gómez-Ruiz, María, Rodríguez-Cueto, Carmen, Luna-Piñel, Eva, Hernández-Gálvez, Mariluz, Fernández-Ruiz, Javier
Publicado no Front Mol Neurosci (2019)

Pharmacokinetics of Sativex(®) in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

Por Fernández-Trapero, María, Pérez-Díaz, Carmen, Espejo-Porras, Francisco, de Lago, Eva, Fernández-Ruiz, Javier
Publicado no Biomolecules (2020)

Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias

Por Rodríguez-Cueto, Carmen, Benito, Cristina, Fernández-Ruiz, Javier, Romero, Julián, Hernández-Gálvez, Mariluz, Gómez-Ruiz, María
Publicado em 2014

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Por Fernández-Ruiz, Javier, Sagredo, Onintza, Pazos, M Ruth, García, Concepción, Pertwee, Roger, Mechoulam, Raphael, Martínez-Orgado, José
Publicado em 2013

Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

Por González, Sara, Valenti, Marta, de Miguel, Rosario, Fezza, Filomena, Fernández-Ruiz, Javier, Di Marzo, Vincenzo, Ramos, José A
Publicado em 2004

Targeting glial cannabinoid CB(2) receptors to delay the progression of the pathological phenotype in TDP‐43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis

Por Espejo‐Porras, Francisco, García‐Toscano, Laura, Rodríguez‐Cueto, Carmen, Santos‐García, Irene, de Lago, Eva, Fernandez‐Ruiz, Javier
Publicado no Br J Pharmacol (2018)

Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults

Por Rubio, Marina, Villain, Hélène, Docagne, Fabian, Roussel, Benoit D., Ramos, José Antonio, Vivien, Denis, Fernandez-Ruiz, Javier, Ali, Carine
Publicado em 2011